Research ArticleConference Proceeding
Session 5: Conference Summary: Key Discussion and Outcomes, Pending Questions, and Proposed Experiments
Glen Bolton and Johannes Blümel
PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 477-481; DOI: https://doi.org/10.5731/pdajpst.2016.006973
Glen Bolton
1Scientific Director, Amgen, 360 Binney Street, Cambridge MA 02142. Telephone: (617) 444-5260; e-mail: ; and
Johannes Blümel
2Paul-Ehrlich-Institut, Virology Department, Paul-Ehrlich-Strasse 51-59 Langen 63225, Germany; 496103773800;
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 70, Issue 5
September/October 2016
Session 5: Conference Summary: Key Discussion and Outcomes, Pending Questions, and Proposed Experiments
Glen Bolton, Johannes Blümel
PDA Journal of Pharmaceutical Science and Technology Sep 2016, 70 (5) 477-481; DOI: 10.5731/pdajpst.2016.006973
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.